Eisai News and Activities

Presence

Eisai is a pharmaceutical company that develops, manufactures, and sells prescription medicines and healthcare products. Its main offerings include neurology, oncology, and gastrointestinal treatments for hospitals, clinics, pharmacies, and patients.

Eisai products and services overview:

Prescription medicines
Cancer treatments
Neurology treatments
Digestive health drugs
Consumer healthcare

Revenue: ~$5 billion

Employees: 11,200

Headquarters: Tokyo, Japan

Eisai is one of the...

Eisai is a company listed under the stock ticker 4523 (JP).

Eisai has a direct presence in 11 countries.

Eisai has 12 subsidiaries including EA Pharma, Eisai Americas and Eisai Australia.

They are in:

Pharmaceuticals92%
Biotechnology8%

Executives

View the org chart displaying its 92 main executives

Most searched biographies at Eisai

Popular executive movements at Eisai

Akiko Nakahama who was Vice President, Chief Portfolio Officer, Asia Filing and Registration, Chief Quality Officer and Japan Regulatory Affairs, becomes Vice President Manufacturing, Quality and Technology, (posted on April 28 2026).
Terushige Iike who was Executive Vice President, Chief Strategy and Planning Officer, becomes Executive Vice President Chief Business Officer, Internal Audit (posted on April 28 2026).

Create your alert
to follow the executive moves at Eisai.